Novo Nordisk

Novo Nordisk Still A Top-Notch Healthcare Growth Story

Novo Nordisk Still A Top-Notch Healthcare Growth Story

Seeking Alpha

Diabetes drugs helps boost Novo Nordisk in Q2

Diabetes drugs helps boost Novo Nordisk in Q2

Yahoo/AP

Novo raises targets on Victoza, insulin demand

Novo raises targets on Victoza, insulin demand

Yahoo/Reuters

Novo Nordisk And Johnson & Johnson Are Winners In Big Pharma

Novo Nordisk And Johnson & Johnson Are Winners In Big Pharma

Seeking Alpha

Novo faces new hurdle in long-acting insulin race

Novo faces new hurdle in long-acting insulin race

Reuters

A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem

A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem

Seeking Alpha

Eli Lilly: A Long-Term Growth Stock

Eli Lilly: A Long-Term Growth Stock

Seeking Alpha

NVO Candidate to Step into Phase III

NVO Candidate to Step into Phase III

Yahoo/Zacks

NVO Candidate to Step into Phase III

NVO Candidate to Step into Phase III

Yahoo/Zacks

New Diabetes Drugs May Push Eli Lilly Higher By 2013

New Diabetes Drugs May Push Eli Lilly Higher By 2013

Seeking Alpha